Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)
CUSIP: 71722W107
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 78,837,943
- Total 13F shares
- 62,330,243
- Share change
- +4,922,446
- Total reported value
- $733,626,032
- Put/Call ratio
- 1.7%
- Price per share
- $11.77
- Number of holders
- 132
- Value change
- +$59,060,064
- Number of buys
- 71
- Number of sells
- 39
Report period
Q3 2025
Institutions
132
Top holders
10
PHAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Ownership snapshot
Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Carlyle Group Inc.
13D/G signal
Carlyle Group Inc.
Evidence rows
50
Latest as of
30 Jun 2025
13F
13D/G
3/4/5
Lead comparable stake: 4.9%
13D/G row: Carlyle Group Inc.
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Carlyle Group Inc. |
13F
13D/G
Company
|
4.9%
from 13D/G
|
$33,534,389
3,496,808 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
4.6%
from 13D/G
|
$31,794,187
3,315,348 shares
|
— | 30 Jun 2025 |
| PRUDENTIAL FINANCIAL INC |
13D/G
|
0%
|
$8,705
2,630 shares
|
-$24,547,397 | 31 May 2025 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
16%
|
$119,553,630
12,466,489 shares
|
— | 30 Jun 2025 |
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
Company · 10%+ Owner
|
9.5%
|
$71,585,245
7,464,572 shares
|
— | 30 Jun 2025 |
| Invesco Ltd. |
13F
Company
|
5.3%
|
$39,703,290
4,140,072 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3.5%
|
$26,730,313
2,787,311 shares
|
— | 30 Jun 2025 |
| Ensign Peak Advisors, Inc |
13F
Company
|
3.2%
|
$24,166,531
2,519,972 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
132
Shares
62,330,243
Rows loaded
132
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
117
Q3 2025 holders
132
Holder diff
15
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend